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We and others have shown previously that pro-
gesterone receptors (PR) form homodimers in
solution in the absence of DNA and that dimers
are the preferential form of receptor that binds
with high affinity to target DNA. To determine the
sequence regions involved in solution ho-
modimerization, wild type PR and truncated PR
proteins were expressed in an insect baculovirus
system. The expression constructs included the
ligand-binding domain [LBD, amino acids (aa)
688–933], the LBD plus hinge (hLBD, aa 634–933),
the hLBD plus the DNA-binding domain (DhLBD,
aa 538–933), and the full- length A and B isoforms
of PR. PR-PR interactions were detected by three
methods, coimmunoprecipitation of the PR frag-
ments with full-length PR-A, pull-down of PR-
polypeptides with polyhistidine-tagged versions
of the same polypeptides immobilized to metal
affinity columns and cooperative ligand-binding
assays (Hill coefficient, nH > 1 indicating PR-PR
interaction). By all three assays, the LBD alone
was not sufficient to mediate protein-protein in-
teraction. However, the LBD did exhibit other
properties ascribed to this domain, including
binding to steroids with a relatively good affinity
and specificity, ligand-induced conformational
changes at the carboxyl terminus tail and binding
of heat shock protein 90 and its dissociation in
response to hormone. Thus, failure of the ex-
pressed LBD to mediate dimerization does not
appear to be due to an extensively misfolded or
unstable polypeptide. The minimal carboxyl-ter-
minal fragment capable of mediating PR-PR in-
teraction was the hLBD construct. However, by
immobilized metal affinity chromatography as-
say, self-association of PR-A was 3.5-fold more
efficient than that of either the DhLBD or hLBD
constructs. An expressed amino-terminal do-
main (aa 165–535) lacking the DNA-binding do-
main, hinge, and LBD was found to physically
associate with PR-A or with another amino-ter-
minal fragment lacking the LBD, but retaining the
DNA-binding domain. These results provide evi-
dence for direct amino-terminal interactions in
the more efficient PR-PR interaction exhibited by
wild-type PR-A, as compared with DhLBD and
hLBD constructs. The overall results of this pa-
per are consistent with the conclusion that the
carboxyl-terminal LBD is not sufficient for medi-
ating PR dimerization and that multiple regions,
including the hinge and amino-terminal se-
quences, contribute either directly or indirectly
to homodimerization of PR. (Molecular Endocri-
nology 11: 1114–1128, 1997)
INTRODUCTION
Members of the nuclear receptor superfamily of eu-
karyotic transcriptional activators can be classified ac-
cording to their specific DNA-binding and dimerization
properties (1–3). Receptors for nonsteroid hormones
such as vitamin D, thyroid hormone, and retinoids bind
preferentially as heterodimers with retinoic acid X re-
ceptor to direct repeat DNA sequence elements sep-
arated by a variable length nucleotide spacer. In con-
trast, the receptors for the classical steroid hormones
bind as homodimers to partial palindromic hexanucle-
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Two dimerization activities have been described
for the steroid hormone subgroup of receptors.
Within the DNA-binding domain (DBD), a short seg-
ment of amino acids near the carboxyl-terminal zinc
finger (D-Box) has been shown by structural studies
(4–6) and mutagenesis (7, 8) to function as an inde-
pendent dimerization interface between two DBDs.
Dimerization mediated by the D-box is dependent
on binding to hormone response elements (HREs)
and appears to be important for restricting receptor
recognition to palindromic sequences separated by
three intervening nucleotides (8). A second dimer-
ization activity resides in a region(s) outside the DBD
that is necessary for receptor dimerization in solu-
tion in the absence of DNA. Indeed, full-length re-
ceptors for estrogen (ER), progesterone (PR), and
glucocorticoids (GR) have been shown to form sta-
ble dimers in solution. In contrast, the DBDs of most
steroid receptors cannot form dimers in solution and
have lower affinities for HREs than full-length recep-
tors, suggesting that solution dimerization is impor-
tant for high-affinity binding to target DNA se-
quences. A minimal sequence that directly mediates
homodimerization in solution has not been well de-
fined. The ligand binding domain (LBD) of ER has
been reported to contain a strong hormone-depen-
dent solution dimerization activity that is required for
high-affinity binding of ER to estrogen response el-
ements (9, 10). Moreover, a conserved heptad re-
peat of hydrophobic amino acids in the LBD was
shown by mutagenesis to be required for efficient
ER homodimerization (9). The LBD of rabbit PR was
also reported to be required for solution dimeriza-
tion, as detected in vivo by cotransfection oligomer-
ization assays (11) and in vitro by coimmunoprecipi-
tation (12). However, experiments with deletion
mutants of GR and androgen receptor (AR) that
retain the DBD have shown that both amino- and
carboxyl-terminal sequences contribute to dimer-
ization and maximal binding to specific DNA se-
quences (13–17), suggesting a role for amino-termi-
nal sequences in solution dimerization.
Solution dimerization has been suggested to be a
regulated step that occurs before DNA binding. As
evidence to support this, several studies have shown
that steroid hormone receptors bind preferentially to
HREs as preformed dimers. For example, dimers of
chicken PR separated from monomers by non-dena-
turing gel electrophoresis were shown to preferentially
bind target DNA (18). Mixing experiments with full-
length GR and its DBD revealed preferential binding of
full-length GR with no evidence of a GR-DBD het-
erodimer bound to DNA (19). Additionally, kinetic and
order of addition experiments with diluted and con-
centrated preparations of GR indicated that ho-
modimerization is a rate-limiting step for high-affinity
binding of GR to target DNA sequences (20).
Human PR is expressed as two different sized pro-
teins from a single gene: full-length PR-B (120 kDa)
and the amino-terminally truncated PR-A (94 kDa) (21).
The two proteins are identical in sequence throughout
the common amino-terminal region and in the DNA-
and steroid-binding domains. Using antibodies
against an epitope in the amino-terminal segment
unique to PR-B, we have shown previously that PR-A
can be coimmunoprecipitated with PR-B in the ab-
sence of DNA, indicating that human PR can form
stable dimers in solution (22). In addition, we showed
a correlation between the extent of solution dimeriza-
tion between PR-A and PR-B and the ability of PR to
bind to its target DNA sequences (22, 23). Dimerization
of PR in solution has also been shown by positive
cooperative ligand-binding studies (24–27).
In the present study, we investigated the contribu-
tion of different regions of human PR to solution dimer-
ization in the absence of DNA. Full-length human PR
and PR fragments were expressed in a baculovirus
insect cell system, and protein-protein interactions
were detected by three different methods; coimmuno-
precipitation, pull-down of PR polypeptides by poly-
histidine-tagged PR-polypeptides immobilized to
metal affinity columns, and positive cooperative ligand
binding. We found that while the LBD alone has suf-
ficient structural information to bind ligands and heat
shock protein 90 and to undergo ligand-induced con-
formational changes, it is not capable of mediating
PR-PR interactions. Addition of hinge sequences was
required to generate a minimal carboxyl terminus frag-
ment capable of PR-PR interactions, whereas addition
of sequences out to the amino terminus of wild type
PR-A further enhanced these interactions. An ex-
pressed amino-terminal domain lacking the DBD and
LBD was able to associate with wild type PR-A or with
another amino-terminal fragment lacking the LBD.
These results suggest a role for the hinge and amino-
terminal sequences, either directly or indirectly, in me-
diating solution dimerization of PR.
RESULTS
Expression of PR and Truncated PR Proteins in
the Baculovirus Insect Cell System
Wild type human PR and the amino-terminal dele-
tion mutants shown in Fig. 1 were expressed in Sf9
insect cells using the baculovirus system. The viral
vectors were constructed as described in Materials
and Methods by inserting human PR cDNAs into
pBlueBacHis so that the recombinant proteins were
expressed with an amino-terminal polyhistidine tag
(6x his) and an enterokinase cleavage site. The three
PR deletion constructs shown contain the following
regions: DBD, hinge, and LBD (DhLBD); the hinge
and LBD (hLBD); and the LBD alone (Fig. 1). The
identities of wild type and truncated PRs were con-
firmed by Western blot of extracts prepared from
infected Sf9 cells using region-specific PR mono-
clonal antibodies (28, 29). The detected molecular
masses of '90 kDa for PR-A (expected is 84 kDa),
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'44 kDa for DhLBD (expected is 41 kDa), '34 kDa
for hLBD (expected is 31.5 kDa), and '28 kDa for
LBD (expected is 25.7 kDa) were close to the ex-
pected values for each expressed protein (Fig. 2). It
should be noted that the electrophoretic mobility of
wild type PR and PR fragments on SDS-polyacryl-
amide gels is slightly slower than predicted from the
molecular mass (21). The faint immunoreactive band
that runs more slowly than PR-A is likely due to a
readthrough product from the baculovirus expres-
sion vector. All PR fragments were detected by the
carboxyl-terminal antibody C-262, while only the
DhLBD was appropriately recognized by the N-559
antibody that binds to sequences immediately ami-
no-terminal to the DBD [amino acids (aa) 551 to
564]. None of the PR fragments were detected by
the amino-terminal antibody AB-52 (Fig. 2).
LBD and Extended Hinge are the Minimal
Sequences Required to Form an Oligomeric
Complex with Wild Type PR-A
Expressed PR fragments (See Fig. 1) were mixed with
purified wild type PR-A, and samples were immuno-
precipitated with the AB-52 monoclonal antibody
(MAb) that recognizes an epitope present in the amino
terminus of PR-A (28). The immunoprecipitates were
analyzed for associated PR fragments by Western blot
with a carboxyl-terminal antibody (C-262) that recog-
nizes both PR-A and all the truncated PR proteins (29).
As a positive control, PR-A association with PR-B was
determined as described previously (22, 23) by coim-
munoprecipitation with B-30, a MAb specific to the
unique N terminus of PR-B (28).
As shown in Fig. 3 (lanes 1–3), the LBD did not
coimmunoprecipitate with PR-A. In contrast, a signif-
icant amount of the LBD plus hinge (hLBD) and DhLBD
truncated proteins were specifically coimmunoprecipi-
tated with PR-A. To quantify the extent of association
with PR-A, the ratio of truncated PR proteins to PR-A
was determined by Phosphorimager analysis of the
Western blots of the immunoprecipitates. A summary
of the quantitative data from multiple experiments is
presented in Fig. 4. No specific association between
the LBD and PR-A was detected. However, the hLBD
(hLBD:PRA ratio 5 0.32 6 0.05) and DhLBD (DhLBD:
PR-A ratio 5 0.43 6 0.04) each associated with PR-A
Fig. 1. Schematic Representation of Wild Type PR and PR
Deletion Constructs Expressed in Baculovirus Sf9 Insect
Cells
PR-B (aa 1–933), PR-A (aa 165–933), the DBD, hinge re-
gion (h), and LBD (DhLBD, aa 538–933); the hinge and LBD
(hLBD aa 634–933); and the LBD alone (aa 688–933). The
region-specific PR monoclonal antibodies (MAbs) used in
these studies are also shown (B-30, AB-52, N-559, and
C-262). 63his, Six sequential N-terminal histidine residues;
EK, enterokinase cleavage site.
Fig. 2. Western Blot Detection of Baculovirus Expressed Wild Type PR-A and PR Truncation Proteins
Insect cells infected with different recombinant baculovirus vectors were exposed to the synthetic progestin R5020 (200 nM)
during the final 6 h of a 48-h viral infection. Whole-cell extracts were prepared in TEDG containing 0.5 M NaCl and were analyzed
by Western blot (goat anti-mouse IgG peroxidase as the detection method) with the following anti-PR-specific MAbs: C-262
against the last 14 amino acids of the carboxyl terminus, N-559 against a sequence in the amino-terminal side of the DBD (aa
551–564) and AB-52 against an epitope in the amino-terminal domain of PR-A (see Fig. 1). Each panel is a Western blot of the
same samples with the different MAbs indicated. The expressed polypetides in each group are: LBD (lane 1), hLBD (lane 2),
DhLBD (lane 3), and PR-A (lane 4).
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to a similar extent as the association of PR-A with
PR-B (PR-A:PR-B ratio 5 0.42 6 0.04) (Fig. 4). These
results suggest that the LBD alone is not able to me-
diate dimerization in solution and that the minimal
carboxyl-terminal fragment capable of mediating
PR-PR interaction requires the LBD plus extended
hinge sequences.
Immobilized Metal Affinity Chromatography
(IMAC) Assay with Polyhistidine-Tagged PR to
Detect Hormone-Dependent PR-PR Interactions
The coimmunoprecipitation assay is limited to detect-
ing interactions between truncated and wild type PR
and thus cannot distinguish whether PR-PR interac-
tions are through the same sequences, as opposed to
different sequence regions of the two interacting
polypeptides. Therefore, to detect protein-protein in-
teractions between similar PR fragments, we have de-
veloped an assay where non-histidine-tagged PR is
pulled down with a polyhistidine-tagged version of the
same PR-polypeptide immobilized to metal affinity
resins. Wild type PR and truncated PR proteins were
expressed from pBlueBacHis vectors as amino-termi-
nal polyhistidine (his)-tagged proteins. Non-histidine-
tagged versions of the same proteins were generated
either by cloning cDNAs into the nonfusion pVL1392
transfer plasmid (PR-A and LBD) or by removal of
amino-terminal polyhistidine sequences by enzymatic
cleavage with enterokinase (hLBD and DhLBD).
The IMAC pull-down assay involves incubating the
polyhistidine-tagged PR with the nontagged version of
the same PR polypeptide. The receptor complexes
were then bound to a metal ion affinity resin (Talon,
CLONTECH, Palo Alto, CA), which has a high affinity
for multiple sequential histidine residues. After wash-
ing extensively with buffer containing 100 mM NaCl
and 15 mM imidazole to remove nonspecifically bound
Fig. 3. Coimmunoprecipitation of Truncated PR Proteins with PR-A
Equal amounts (based on steroid-binding assays and Western blot analysis) of expressed LBD (lanes 1–3), hLBD (lanes 4–6),
or DhLBD (lanes 7–9) were incubated in the absence or presence of PR-A and immunoprecipitated with AB-52 by absorption to
protein A Sepharose. PR-A and PR truncated proteins were bound to R5020 before extraction from Sf9 cells. As a positive control
(lanes 10–12), PR-A was incubated with PR-B and immunoprecipitated with B-30, a MAb that recognizes an epitope in the unique
extended amino terminus of PR-B. The resins were washed with TEG containing 100 mM NaCl and extracted with SDS-sample
buffer. Extracted samples were analyzed by Western blot using C-262 that detects all PR fragments as well as full-length PR (see
Fig. 1). Western blot results were arranged in groups of three samples for each assay, which included the input of the PR
polypeptide, nonspecific absorption of the PR fragment to protein A Sepharose in the absence of PR-A, and specific association
in the presence of PR-A. The heavy chain of the MAb and secondary IgG also appear in the immunoprecipitates and are indicated
by an arrow at ' 50 kDa.
Fig. 4. Quantification of Coimmunoprecipitation Results
Results of multiple coimmunoprecipitation experiments,
similar to that in Fig. 3, were quantitated as the ratio of PR
fragment to PR-A in the immunoprecipitate after subtraction
of the nonspecific binding of PR fragments to protein-A-
Sepharose in the absence of PR-A. Western blot bands were
quantified by direct scanning of Western blots for radioactiv-
ity (35S Protein A) by Phosphorimager analysis. Values are the
mean 1 SEM of the ratios of PR fragments to full-length PR in
the immunoprecipitates: LBD/PR-A (n 5 4), hLBD/PR-A (n 5
8), DhLBD/PR-A (n 5 5), and PR-A/PR-B (n 5 14).
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proteins, proteins that remained bound were eluted
and analyzed by Western blot. Because the polyhisti-
dine tag and enterokinase cleavage site adds 29
amino acids to the amino terminus, the polyhistidine-
tagged proteins can be distinguished easily from non-
fusion proteins on Western blots by an approximate 3
kDa difference in molecular mass. The presence or
absence of the polyhistidine sequences was also con-
firmed by Western blot analysis with an antibody to the
polyhistidine tag leader sequence (data not shown).
The results of a representative IMAC pull-down ex-
periment comparing the ability of truncated PRs and
wild type PR-A to self-associate are shown in Fig. 5.
Little or no interaction was detected between LBD and
LBDhis, whereas a significant amount of hLBD,
DhLBD, and PR-A were each pulled down in a specific
manner by hLBDhis, DhLBDhis, and PR-Ahis, respec-
tively. To quantitate the extent of these protein-protein
interactions, the ratios of non-histidine- to polyhisti-
dine-tagged PR polypeptides specifically bound to
Talon resins were determined by PhosphorImager
analysis of the Western blots from multiple indepen-
dent IMAC assays. The results given in Table 1 confirm
that no specific LBD-LBDhis interaction was measur-
able. In contrast, hLBD and DhLBD constructs both
exhibited substantial self-association, the extent of
which was similar for both. Interestingly, the efficiency
of self-association of PR-A was 3.5-fold higher than
that obtained with either DhLBD or hLBD (P , 0.05).
The self-association of wild type PR-A and PR frag-
ments shown in Fig. 5 and summarized in Table 1 was
observed in the presence of the synthetic progestin
agonist, R5020. When similar experiments were done
in the absence of ligand, little to no specific interac-
tions were detected (data not shown), indicating that
these PR-PR interactions measured by IMAC pull-
down assay are hormone-dependent.
It has been suggested that contaminating DNA in
cell extracts can stabilize protein dimerization, and
that protein-protein interactions may only appear to be
DNA-independent (30). To determine whether PR-PR
interactions detected were in fact DNA independent or
not, micrococcal nuclease was added to Sf9 extracts
used in IMAC pull-down assays under conditions de-
termined in control reactions to give complete diges-
tion to test plasmid DNA (see Materials and Methods).
These results suggest that PR-PR interactions de-
tected are not dependent on contaminating DNA in
cell extracts.
Separately Expressed PR Amino Terminus
Interactions
Self-association of wild type PR-A was more efficient
than that of the truncated PR proteins, suggesting that
amino-terminal sequences have a role in homodimer-
ization of PR. To determine whether amino-terminal
sequences affect homodimerization directly or indi-
rectly, we expressed the amino-terminus of PR-A in
baculovirus as a polyhistidine-tagged polypeptide.
This construct extends from the extreme amino termi-
nus of PR-A to the amino-terminal side of the DBD (aa
165 to 535) and thus lacks the DBD, hinge, and LBDFig. 5. PR-PR Interactions Detected by IMAC Pull-Down As-
say
Whole-cell extracts of infected Sf9 cells containing PR or
PR truncation proteins were mixed with equal amounts (de-
termined by steroid binding and Western blot analysis) of
polyhistidine-tagged versions of the same PR polypeptides
and incubated for 30 min on ice. Samples were brought to a
concentration of 15 mM imidazole and 100 mM NaCl and
incubated with Talon metal ion affinity resins for 1 h at 4 C.
After washes of the resin, bound proteins were eluted with
2% SDS and analyzed by Western blot with the C-terminal
MAb, C-262, using [35S]Protein A and autoradiography as the
detection method. Western blot results were arranged in
groups of four samples for each assay which included input
of polyhistidine-tagged (his) and non-fusion PR-polypep-
tides, nonspecific binding of the non-fusion PR polypeptides
to Talon resins, and specific binding of non-fusion polypep-
tides (open arrows) in the presence of the polyhistidine-
tagged PR polypeptide (closed arrows).
Table 1. Quantification of PR-PR Protein Interactions by
IMAC Pull-Down Assays
Construct Ratio of Nonfusion PR:PRhis (Mean 6 SEM)
LBD 0.02 6 0.01 (n 5 4)
hLBD 0.13 6 .04 (n 5 4)
DhLBD 0.17 6 .08 (n 5 4)
PR-A 0.57 6 .05 (n 5 6)
Multiple IMAC pull-down assays were quantified by deter-
mining the ratio of nonfusion to histidine-tagged PR polypep-
tides specifically bound to Talon resins. Values (mean 6 SEM)
were determined by direct PhosphorImager scanning of
Western blots for radioactivity (bound [35S]Protein A) in the
receptor bands.
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(see schematic in Fig. 6). This amino-terminal domain
polypeptide, expressed with a polyhistidine tag (PR-
ANhis), was observed by IMAC pull-down to interact
efficiently with non-histidine-tagged PR-A (bound to
hormone) as shown by the Western blot results in Fig.
6 (left panel), where binding of PR-A to Talon resins
was dependent on the presence of the ANhis PR frag-
ment. Similarly, the ANhis PR fragment specifically
pulled down a non-histidine-tagged amino-terminal
fragment of PR-A that contains the DBD but lacks all
of the LBD (ANDBD) (Fig. 6). Multiple independent
protein-protein interaction assays were done with
these amino-terminal PR fragments, and the results
were quantitated by Phosphorimager analysis of the
Western blots to determine the ratios of ANhis asso-
ciated with non-histidine-tagged PR-A or the ANDBD
fragment. The efficiency of interaction of the amino-
terminal fragment (ANhis) with PR-A (PR-A:ANhis ra-
tio 5 0.47 6 0.09; n 5 4) was greater than that of the
self-association observed between carboxyl-terminal
fragments (DhLBD and hLBD), but equal to or less than
that of interactions between PR-A and PR-A. The in-
teraction between two amino-terminal fragments
(ANDBD:ANhis ratio 5 0.17 6 0.03; n 5 4) was similar
quantitatively to the self-interactions of the carboxyl
terminal fragment (see Table 1). These results indicate
that the amino terminus provides direct protein-pro-
tein contacts that contribute to PR homodimerization
and that these interactions in combination with C-
terminal interactions account, in part, for the more
efficient dimerization of full-length PR-A. The more
efficient interaction of the amino-terminal fragment
with PR-A than with another amino-terminal fragment
lacking the LBD, further suggests that there is an
amino-terminal-carboxyl-terminal interaction that con-
tributes to PR dimerization.
Hinge Sequences are Required for Positive
Cooperative Binding of Progesterone to the LBD
As an independent approach for detecting dimeriza-
tion in solution, saturation progesterone-binding ex-
periments were performed with wild type PR-A and
truncated PR proteins, and the data were analyzed by
Scatchard plot. As determined by the limiting slope of
the Scatchard plot (Fig. 7), no difference was detected
in the affinity of PR-A, DhLBD, and hLBD for [3H]pro-
gesterone; the values obtained for association con-
stants (Ka) were between 0.45 and 0.65 nM
21 (Table 2).
In contrast, the affinity of the LBD for [3H]progesterone
was lower by approximately 7-fold; 0.07 nM21 (P ,
0.05, Table 2). Also shown in Fig. 7, the Scatchard
plots for the binding of [3H]progesterone to PR-A,
the DhLBD, and the hLBD were convex, which is con-
Fig. 6. Direct Interactions between Amino-Terminal Do-
mains
Top, Schematic of non-histidine-tagged PR-A (aa 165 to
933) and amino-terminal domains of PR-A: ANDBD that con-
tains the amino terminus, DBD, and hinge region of PR-A (aa
165 to 688) in which the polyhistidine tag has been removed
by cleavage with enterokinase; and ANhis that contains the
amino terminus only of PR-A (165 to 535) with a polyhistidine
tag at the N terminus. Bottom, ANhis was incubated for 30
min at 4 C with either full-length PR-A or ANDBD. Samples
were then bound to Talon resins, eluted, and analyzed by
Western blot with AB-52, which recognizes an epitope in the
amino terminus common to all three polypeptides. Also in-
cluded are Western blots of input PR-A, ANDBD, ANhis, and
nonspecific binding of non-histidine-tagged PR-A and
ANDBD alone.
Fig. 7. Positive Cooperative Binding of Progesterone as an
Independent Assay for PR Dimerization
Extracts containing PR-A and PR truncation proteins, ex-
pressed in Sf9 insect cells, were incubated in the presence of
varying concentrations of [3H]progesterone in TEDG buffer
(pH 7.4) at 0 C for 2 h and specific progesterone binding to
PR was determined by DCC assay. Shown are the Scatchard
plots of representative experiments with PR-A (F), DhLBD
(M), hLBD (l), and LBD (). The corresponding Hill coeffi-
cients (nH) and number of binding sites (Bmax) for the individ-
ual experiments shown are nH 5 1.25 6 0.001 for PR-A (Bmax
5 1.37 nM); nH 5 1.42 6 0.14 for the DhLBD (Bmax 5 2.19 nM);
nH 5 1.33 6 0.12 for the hLBD (Bmax 5 1.89 nM); and nH 5
0.88 6 0.12 for the LBD (Bmax 5 1.29 nM).
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sistent with a cooperative binding mechanism. In
contrast, the Scatchard plot of the binding of [3H]pro-
gesterone to the LBD was nearly linear, which is con-
sistent with a noncooperative mechanism.
The cooperativity of binding [3H]progesterone was
further investigated by determining the Hill coefficient
from the saturation binding data. A Hill coefficient
greater than 1 is indicative of a positive cooperative
binding mechanism, in which the binding of ligand to
one site increases the binding affinity for a second site.
Because PR has only one steroid binding site per
polypeptide, positive cooperativity requires protein-
protein interaction and therefore is also a measure of
dimerization. A Hill coefficient near 1 is described as
noncooperative and indicates that either the protein is
monomeric or that site-site interactions do not occur
(31).
The Hill coefficients (nH) of binding [
3H]progesterone
to DhLBD and hLBD were indistinguishable from that
of PR-A (Table 2). Additionally, the values were similar
to that previously reported for human PR-A, nH 5 1.34
(25), and to the maximal value reported for the bovine
uterine progesterone receptor, nH 5 1.2 (24, 25, 27).
Moreover, these values are consistent with a moder-
ately positive cooperative binding mechanism. In con-
trast, the Hill coefficient of binding [3H]progesterone to
the LBD was significantly reduced, nH 5 0.89 (P ,
0.05; Table 2). Thus, the positive cooperative proges-
terone binding detected with hLBD and the noncoop-
erative binding of the LBD provide further evidence
that the hinge is essential for PR homodimerization
and that the LBD alone is unable to mediate protein-
protein interaction.
The LBD is Sufficient for Supporting Other
Functions Ascribed to this Domain
Because the LBD was not able to mediate protein-
protein interaction, we investigated whether it has suf-
ficient structural information to mediate other proper-
ties ascribed to this domain. As shown in Fig. 7, the
LBD is capable of binding progesterone, albeit with a
7-fold lower affinity than wild type PR-A (Table 2). In
addition, as determined by competitive inhibition bind-
ing curves, the LBD exhibited steroid binding speci-
ficity similar to that of PR-A by binding the synthetic
progestin R5020 and the progestin antagonist RU486,
but not other steroids (Fig. 8A).
As reported previously, the carboxyl-terminal tail of
human PR undergoes a conformational change in re-
sponse to binding progestin agonists that is distinct
from that induced by antagonists. This was detected
by partial proteolytic digestion assay (32) and by dif-
ferential recognition by the carboxyl-terminal C-262
MAb (29). As confirmed in Fig. 8B, wild type PR-A was
efficiently recognized and immunoprecipitated by
C-262 when bound to the antagonist [3H]RU486, but
not when bound to the agonist [3H]R5020. The amino-
terminal MAb AB-52 did not exhibit this differential
reactivity and efficiently immunoprecipitated both ag-
onist- and antagonist-bound PR-A. Baculovirus-ex-
pressed LBD (without hinge sequences), bound to
agonist or antagonist, displayed the same differential
recognition by the C-262 MAb as wild type PR-A (Fig.
8B). Thus, the LBD is capable of undergoing differen-
tial ligand-induced conformational changes at the car-
boxyl-terminal tail in a manner similar to that of PR-A.
Studies with other steroid hormone receptors indi-
cate that heat shock protein 90 (hsp90) binds to se-
quences within the LBD and functions to assist in
protein folding to maintain receptor in a proper con-
formation in the absence of hormone (33–35). To de-
termine whether the LBD of human PR is sufficient to
bind hsp90, an LBD construct (lacking the hinge) was
synthesized in vitro in rabbit reticulocyte lysates in the
presence of [35S]methionine. In rabbit reticulocyte ly-
sates, newly synthesized GR (34) and chick PR (35)
bind efficiently to hsp90, which can be detected by
coimmunoprecipitation of the radiolabeled receptor
with a MAb, 3G3, to hsp90 (36). Furthermore, this
interaction can be dissociated by hormone in the pres-
ence of ATP and elevated temperature (34, 35). As
shown in Fig. 8C, the synthesized [35S]LBD of human
PR was specifically coimmunoprecipitated by the MAb
3G3, but was not pulled down by a control antibody
(rabbit anti-mouse, RAM). Addition of R5020 in the
presence of ATP and elevated temperature (30 C) re-
sulted in LBD dissociation from hsp90 as indicated by
the loss of immunoprecipitation of [35S]LBD by 3G3. It
should also be noted in Fig. 8C, that the addition of
R5020 to the LBD resulted in loss of specific reactivity
with the PR carboxyl-terminal MAb C-262, consistent
with the immunoprecipitation data in Fig. 8B. Thus the
LBD, expressed independently of other receptor do-
mains, assumes the conformation required for binding
and dissociation from hsp90 in a ligand-dependent
manner.
DISCUSSION
The present study has shown by three independent
assays, coimmunoprecipitation, IMAC pull-down, and
Table 2. Binding of [3H]Progesterone to PR-A and PR
Fragments




LBD 0.89 6 0.03a 0.07 6 0.01a (n 5 7)
hLBD 1.23 6 0.05 0.45 6 0.05 (n 5 7)
DhLBD 1.33 6 0.04 0.68 6 0.06 (n 5 5)
PR-A 1.27 6 0.05 0.49 6 0.05 (n 5 13)
Hill coefficients were calculated by nonlinear regression anal-
ysis of bound vs. free [3H]progesterone. The association con-
stants (Ka) were calculated from the limiting slope of the
Scatchard plot.
a The nH and Ka values for LBD were significantly lower than
that of other PR constructs. (P , 0.05).
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positive cooperative ligand binding, that the LBD of PR
is not capable of mediating protein-protein interaction.
Furthermore, the LBD exhibited a somewhat lower
binding affinity for progesterone (7-fold) than wild type
PR. This suggests that this domain does not contain
sufficient structural information and/or sequences for
mediating homodimerization and for wild type affinity
for ligand. In contrast, the LBD was capable of carrying
out other properties ascribed to this domain in a man-
ner similar to that of wild type PR-A, including ligand-
binding specificity, ligand-induced conformational
changes, and hormone-dissociable binding of hsp90.
These data strongly suggest that this domain alone
can assume the appropriate conformation required for
these other properties. Thus, the failure of the LBD to
mediate PR-PR interaction does not appear to be due
Fig. 8. Recombinant LBD Exhibits Several Properties Similar to that in the Context of Native PR
A, Steroid binding specificity. Cytosols prepared from Sf9 cells expressing LBD or PR-A were bound to a saturating dose of
[3H]R5020 (10 nM) in the presence of increasing fold-excesses of unlabeled steroids (DEX, dexamethasone; DHT, dihydrotest-
osterone). Bound and free [3H]R5020 were separated by DCC. Data are given as a percentage of total [3H]R5020 binding obtained
in the absence of unlabeled steroid. B, Ligand-induced conformational changes at the carboxyl-terminal tail. LBD and PR-A
expressed in Sf9 cells were prepared as a cytosolic fraction and were incubated for 8 h at 4 C in the presence of labeled [3H]R5020
or [3H]RU486 followed by an additional 1-h incubation at 4 C in 0.4 M NaCl to transform the receptor-ligand complex to its active
form. Samples were then incubated for 4 h at 4 C with 200 ml suspension of protein A Sepharose that had been precoated with
C-262, AB-52, or a control unrelated antibody. Protein A Sepharose was washed by centrifugation with TEG, extracted with 1 ml
ethanol for 1 h at 37 C, and centrifuged, and the supernatant was quantified for [3H] radioactivity by liquid scintillation counting.
Specific immunoabsorbed [3H] counts were determined by substraction of [3H] counts absorbed by the control MAb (less than
10% of that with receptor MAbs). The data are given as the percent of total input PR-[3H] ligand complexes that were specifically
immunoprecipitated. C, In vitro synthesized LBD binds hsp90 in a hormone-dependent manner. The LBD (lacking hinge
sequences) of human PR was synthesized in vitro in a coupled transcription/translation assay in the presence of [35S]methionine
and 20 mM sodium molybdate. Samples were treated for 30 min at 30 C with or without R5020 (100 nM) in the presence of 5 mM
ATP. Samples were then cooled to 4 C and immunoprecipitated with the following MAbs: 3G3 (specific to hsp90), C-262 (specific
to C terminus of PR) or a control rabbit antimouse (RAM) IgG. Immunoprecipitated [35S]LBD (;27 kDa) was detected by
SDS-PAGE and autoradiography.
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to extensive misfolding or destabilization of the ex-
pressed polypeptide in the absence of other receptor
sequences. The minimal carboxyl-terminal construct
capable of mediating PR-PR interaction was the LBD
with upstream hinge region sequences (hLBD). The
hLBD interacted with PR-A by coimmunoprecipitation
and mediated self-association as detected by IMAC
pull-down and positive cooperative ligand-binding as-
says. Furthermore, the hLBD exhibited high affinity
binding of progesterone similar to wild type PR. We
conclude from these results that the hinge of human
PR has an important role in mediating homodimeriza-
tion and high-affinity ligand binding.
The hinge region of nuclear receptors has generally
been thought to provide a flexible link between the
LBD and DBD and not to have other functional roles.
This belief in part is due to the fact that the hinge
region is generally a hydrophilic, poorly conserved
sequence region among superfamily members (37).
However, there is growing evidence that the hinge
does have other important functional roles. For exam-
ple, nuclear localization sequences have been
mapped to the hinge region of certain steroid recep-
tors (11, 38). More recently it has been shown that the
hinge region of retinoid acid (RAR) and thyroid recep-
tors (TR) has conserved residues that form a binding
site for corepressor molecules (39, 40). In addition, the
binding site for estrogen receptor interaction with the
TATA-binding protein-associated factor TAFII30 was
mapped to the hinge region (41). An alternative func-
tion has been suggested by studies with the RORa
orphan nuclear receptor, where the hinge was shown
to be essential for proper alignment of the DBD to
produce maximal bending of target DNA (42). In the
present study, we show that the hinge is also involved
in homodimerization of PR in solution, suggesting an-
other function for this region. However, it is not known
whether this function of the PR hinge is direct by
providing interfaces for protein-protein contact or in-
direct by conferring the appropriate conformation for
protein-protein interaction through other more carbox-
yl-terminal sequences in the LBD. Our studies with
human PR also show that the hinge influences the
affinity of the LBD for progesterone. The expressed
LBD alone bound progesterone with a 7-fold lower
affinity than full-length PR, whereas the LBD ex-
pressed with the extended hinge sequences bound
ligand with the same affinity as full-length PR.
Among different members of the nuclear receptor
family the hinge region has been reported to have a
variable influence on ligand-binding affinity. In the
case of ER, there appears to be little or no requirement
of the hinge for the LBD to bind estradiol with high
affinity (43, 44). Indeed, the purified LBD alone of
human ER, expressed in bacteria, bound estradiol sto-
ichiometrically and with an affinity equal to that of
full-length receptor (44). Studies with GR and miner-
alocorticoid receptor (MR) are complicated by the fact
that ligand binding is more dependent on association
with hsp90 than it is with other steroid receptors.
However, the LBD of MR (lacking hinge sequences),
expressed in bacteria and reconstituted to bind hsp90
from rabbit reticulocyte lysates, bound hormone with
the same affinity as wild type MR, suggesting that the
hinge of MR is not required for the LBD to bind ligand
(45). In the case of GR, the influence of the hinge on
steroid binding is less clear. When an LBD construct of
rat GR with the extended hinge region sequences was
synthesized in vitro in rabbit reticulocyte lysates, it
associated with hsp90 and bound hormone with high
affinity (46). In other studies with rat GR, the LBD alone
(aa 537 to 795) expressed in mammalian cells was
highly unstable resulting in no detectable protein or
steroid binding. However, fusion of the rat GR LBD to
other unrelated proteins (b-galactosidase and dihy-
drofolate reductase) yielded stable polypeptides that
bound ligand with high affinity approaching that of
native GR. These findings suggest that the LBD of GR
is not functionally independent and requires the influ-
ence of other receptor sequences on tertiary structure
for its ligand-binding activity (47). Whether the hinge
region could substitute for the fusion protein se-
quences was not investigated (47). In apparent con-
trast to most reports with the classical steroid recep-
tors, hinge region sequences have been observed to
be essential for ligand binding of two nonsteroid nu-
clear receptors. No ligand binding was detectable with
the expressed LBDs of chicken or human thyroid hor-
mone receptors (TR) and retinoic acid receptor-a
(RARa) unless these domains were expressed with
either the carboxyl-terminal half of the hinge or the
entire hinge region (48–50). Interestingly, the ex-
pressed LBD of RARa, with extended hinge se-
quences, bound all-trans-retinoic acid similar to that of
full-length RARa with a strong positive cooperative
mechanism (nH 5 2.0), which was correlated with the
formation of RARa homodimers (50).
To examine the ability of like PR polypeptides to
mediate protein-protein interaction, we used an IMAC
pull-down assay instead of the more widely used as-
say with glutathione-S-transferase (GST) fusion pro-
teins immobilized to glutathione resins. The large GST
fusion (27 kDa) is more likely to affect PR structure and
function than the much shorter polyhistidine/enteroki-
nase fusion sequence (3 kDa). In addition, GST itself
has been reported to mediate dimerization (51, 52). By
comparing ligand-binding and DNA-binding proper-
ties of nonfusion and polyhistidine-tagged PR, we
have determined that the polyhistidine fusion se-
quences at the amino terminus have no effect on these
PR functions (data not shown). Immobilized polyhisti-
dine fusion proteins have been used previously to
study protein-protein interactions between het-
erodimer subunits of human immunodeficiency virus-
reverse transcriptase (53), homodimerization of the
upstream stimulatory transcription factor of the major
late adenovirus promoter (54), and the physical asso-
ciation between bacterial heat shock proteins and the
heat shock transcription factor (55). To our knowledge,
this is the first study to use immobilized polyhistidine-
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tagged steroid receptors to investigate receptor
dimerization. In addition, this assay should be amena-
ble to studying steroid receptor interactions with other
proteins.
Although the IMAC, coimmunoprecipitation, and co-
operative binding assays were consistent in detecting
the hLBD as the minimal carboxyl-terminus fragment
capable of mediating PR-PR interactions, there was a
quantitative discrepancy between IMAC and other as-
says when comparing the efficiency of dimerization of
the different PR constructs. Coimmunoprecipitation
and cooperative steroid binding results indicated that
protein-protein interactions mediated by PR-A and
DhLBD were no greater than that of the minimal car-
boxyl-terminal hLBD construct. However, by IMAC as-
say, self-association of PR-A was more efficient than
that of either hLBD or DhLBD. The reason for this
apparent discrepancy is not known. One possibility is
that cooperative binding assays may not be capable of
detecting this level of quantitative difference. The dif-
ference between coimmunoprecipitation and IMAC re-
sults likely stems from the fact that PR-A association
with PR-B was used as the 100% control for dimer-
ization of wild type PR, whereas IMAC used PR-A/
PR-A interaction which is not possible to detect by
coimmunoprecipitation. We know from IMAC results
that the efficiency of interaction for the different pos-
sible dimer forms of human PR is graded where AA .
AB . BB (M. Tetel and D. Edwards, unpublished).
Thus, if it were possible to measure PR-A homo-
dimerization by coimmunoprecipitation, we predict
that it would also be more efficient than association of
either DhLBD or hLBD with PR-A.
Although it is not known whether our physical as-
sociation assays detect dimerization or higher order
PR-PR interactions, there are several lines of evidence
to suggest that they detect physiologically relevant PR
dimerization as opposed to nonspecific aggregation.
First, by IMAC assays, PR-PR interactions were de-
tected only when fusion and nonfusion PR polypep-
tides were mixed in solution before immobilization to
metal resins; no interactions were detected when the
polyhistidine-tagged PR polypeptide was immobilized
first. This suggests that preformed dimers can ex-
change subunits in solution more readily than immo-
bilized PR-dimers. Second, self-association of PR-A
and the PR fragments by IMAC assay were found to be
hormone dependent. PR-PR interactions were not de-
tected in the absence of ligand. Third, positive coop-
erative binding results detect only functional PR ca-
pable of high-affinity steroid binding, indicating
specific site-site interactions. Further analysis of wild
type PR and truncated PR proteins by gel filtration and
other hydrodynamic methods, as well as structural
analysis, will be necessary to determine more defini-
tively the stoichiometry of the PR-PR interactions de-
tected in these studies.
The present studies, which used baculovirus-ex-
pressed PR in cell extracts, do not address the issue
of whether PR-PR interactions detected are direct or
indirect through an intermediary protein. However, it
should be noted that our previous experiments by
coimmunoprecipitation did demonstrate a physical
association between highly purified PR-A and PR-B,
indicating that dimerization of full-length PR is direct
(56). However, we have yet to examine the ability of
purified PR fragments to mediate protein-protein
interaction.
The estrogen receptor has been studied more ex-
tensively than other steroid receptors for characteriza-
tion of sequences that mediate homodimerization in
solution. Mutagenesis studies have shown that the ER
LBD contains a strong dimerization activity that is
dependent on a conserved heptad repeat of hydro-
phobic sequences in the carboxyl-terminal half of the
LBD while the amino terminus does not appear to be
involved in dimerization (9, 10). Blocking experiments
with synthetic peptides have also shown that a phos-
phorylated tyrosine residue (Tyr 537) and surrounding
sequences located more carboxyl-terminal than the
core heptad hydrophobic repeats is also important for
ER dimerization and DNA binding (57). The phosphor-
ylated peptide at Tyr 537 inhibited dimerization,
whereas the nonphosphorylated peptide did not, sug-
gesting that this sequence motif forms a direct dimer-
ization interface that is regulated by phosphorylation
(57). As further evidence that homodimerization of ER
is mediated predominantly by carboxyl-terminal inter-
actions within the LBD, the expressed LBD is capable
of spontaneously dimerizing in solution (58–60). This
clearly contrasts with our results with the LBD of PR,
which was not able to homodimerize. Several studies
have also suggested that GR and AR may use different
sequence regions than ER for homodimerization in
solution. Analysis of various deletion mutants of AR
and GR have shown that the amino terminus has a
strong influence on homodimerization and binding af-
finity for GREs, perhaps more so than the carboxyl
terminus (14, 16, 17, 19). Also, deletion of the con-
served heptad repeat carboxyl-terminal sequences in
AR, which are important for ER homodimerization in
solution, had little effect on AR dimerization and DNA-
binding affinity (15). However, another study showed
that the expressed LBD of AR was able to form stable
homodimers in solution (52). Thus, it has been sug-
gested that the amino- and carboxyl termini of AR/GR
work in synergy to mediate homodimerization (16, 17).
As further evidence that homodimerization of ER may
be different than other steroid receptors, ER dimers in
solution appear to be more stable than PR and GR
dimers (26, 61, 62). In a direct comparison, ER was
determined to form dimers at a lower concentration
than PR, suggesting that ER has a higher dimerization
constant than PR (26).
Similar to studies with AR and GR, the present re-
sults indicate that amino-terminal sequences in human
PR also contribute to solution dimerization. Although
the hLBD construct was the minimal carboxyl-terminal
fragment to mediate PR-PR interaction, full-length
PR-A showed a 3.5-fold more efficient self-association
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than either the DhLBD or hLBD constructs (Table 1).
Additionally, two amino-terminal fragments lacking the
LBD were able to physically associate with each other,
suggesting that the amino terminus contributes di-
rectly to homodimerization of PR (Fig. 6). These results
are consistent with protein contacts between two ami-
no-termini accounting, at least in part, for the higher
efficiency of PR-A homodimerization as compared
with that of the carboxyl-terminal hLBD and DhLBD
constructs. Our results differed from a coimmunopre-
cipitation study with rabbit PR that showed an amino-
terminal mutant lacking the hinge and LBD was not
able to self-associate. It was concluded from this
study with rabbit PR that the LBD was required for
homodimerization and that the amino terminus was
not involved (12). The reason for the apparent discrep-
ancy between the results with rabbit PR (12) and our
present findings is not known. One possibility is the
use of different methodologies to analyze PR-PR in-
teractions. Alternatively, this may be due to a mecha-
nistic difference between human and rabbit PR. Rabbit
PR is expressed only as the larger B isoform, and thus
coimmunoprecipitation was done with amino-terminal
fragments containing sequences in the extended
amino terminus of PR-B. Our studies detected amino-
terminal PR-PR interactions with constructs lacking
the amino-terminal extension of PR-B. We have ob-
served previously by cooperative ligand binding (25)
and IMAC pull-down assays (M. J. Tetel, M. Altmann,
and D. Edwards, unpublished), that the unique amino-
terminal segment of PR-B has a repressive effect on
solution dimerization of PR. As further evidence that
amino-terminal sequences contribute to PR ho-
modimerization, we have analyzed the PR fragments
used in this study that contain the DBD for relative
binding affinity for target DNA sequences. As deter-
mined from saturation binding analysis by electro-
phoretic gel mobility shift assay, amino-terminal frag-
ments lacking the LBD (ANDBD) bound to DNA as
dimers with almost the same affinity as full length PR
dimers. In contrast, the carboxyl terminal fragment
(DhLBD) had a significantly lower binding affinity sug-
gesting that amino-terminal sequences have a stron-
ger influence on dimerization and DNA binding affinity
than carboxyl-terminal sequences (V. Melvin and D.
Edwards, unpublished).
Recent mammalian cell two-hybrid assays with sep-
arately expressed domains of AR have suggested a
somewhat different role for the amino terminus in ho-
modimerization. Separately expressed carboxyl-ter-
minal LBD constructs of AR did not make measurable
protein-protein interactions in vivo (63). However, an
interaction was detected between separately ex-
pressed amino-terminal domains, and a stronger hor-
mone-dependent interaction was detected between
amino and carboxyl-terminal constructs (63). From
these results the authors suggested that AR may form
homodimers through an antiparallel interaction be-
tween the amino and carboxyl terminus. In a similar
study, the separately expressed amino- and carboxyl-
terminal domains of ER were shown to functionally
interact in vivo (64). Our finding that the separately
expressed amino-terminal domain of PR interacted
more strongly with full-length PR-A than it did with
another expressed amino-terminal fragment lacking
the LBD, suggests that human PR may also exhibit an
interaction between its amino- and carboxyl-terminal
domains. Whether these interactions might contribute
to PR homodimerization, to an intramolecular interac-
tion within a PR monomer, or both, remains to be
determined.
In summary, our results are consistent with the con-
cept that homodimerization of PR in solution is not
mediated by a single discrete domain, but that multiple
regions, including the hinge and amino terminus, con-
tribute to PR dimerization. Further studies will be re-
quired to determine which regions contribute directly





yl-19-norpregna-4,9-diene-3, 20-one; 87 Ci/mmol) and un-
labeled R5020 were obtained from Dupont/New England
Nuclear Products (Boston, MA). Unlabeled RU486 (Mife-
pristone, 17-hydroxy-11[4-dimethlyaminophenyl] 17-pro-
pynyl-estra-4, 5-diene-3-one) was a gift from Roussel-
UCLAF (Romainville, France). [1,2-3H(N)]Progesterone
(50.0–51.5 Ci/mmol:1, 850.0–1, 905.5 GBq/mmol) was ob-
tained from DuPont/NEN Research product (Boston, MA).
Unlabeled steroids (progesterone, estradiol, dexametha-
sone, and dihydrotestosterone) were purchased from
Sigma Chemical Company (St. Louis, MO). Metal ion af-
finity resins (Talon) were obtained from CLONTECH (Palo
Alto, CA). Monoclonal antibodies against human PR in-
clude AB-52, which recognizes both the A and B isoforms
and B-30, which recognizes only PR-B (28). C-262 is a
monoclonal antibody directed against the last 14 amino
acids of the carboxyl-terminal end of PR (29). The MAbs
H-130 and N-559 were generated against amino acids
669–682 of the hinge region and amino acids 551–564 of
the DBD of human PR, respectively. The 3G3 MAb to
hsp90 was provided by Gary Perdew (36).
Construction of Recombinant Baculovirus Vectors for
PR and PR Fragments
Recombinant viral vectors expressing full-length PR-A or
PR-B as non-fusion proteins were constructed using the
transfer plasmids pVL1392 and pVL1393 (Invitrogen, San
Diego, CA) as described previously (65). Viral vectors, which
generate amino-terminal polyhistidine (6x) sequences (N. L.
Weigel, B. W. O’Malley, M. J. Tetel, and D. P. Edwards,
unpublished), were constructed by insertion of PR-A or PR-B
cDNAs into BamHI sites of pBlueBacHis (Invitrogen). A bac-
ulovirus vector expressing the DhLBD fragment of PR (the
entire DBD, hinge region, and LBD of PR) was constructed by
restriction digest of the plasmid phPR-A obtained from
Donald McDonnell (66) with AccI, filling in of the 59 overhang
by Klenow DNA polymerase, and restriction digestion with
EcoRI yielding a DNA fragment encoding aa 538–933 of
human PR. The AccI/EcoRI fragment was then gel purified
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and inserted between the BamHI (after filling in to blunt end)
and EcoRI sites in pBlueBacHis2A. A baculovirus vector ex-
pressing the hLBD fragment of PR (the LBD plus adjacent
hinge sequences as an N-terminal polyhistidine-tagged fu-
sion protein) was constructed by restriction digestion of the
plasmid pT7hbPR-A obtained from Ming Tsai and Bert
O’Malley (Baylor College of Medicine, Dallas, TX) (32) with
StyI and EcoRI to yield a fragment encoding amino acid
residues of PR from 634 to 933. After blunt ending, this
restriction fragment was gel purified and inserted into
BamHI and HindIII sites of the multiple cloning cassette of
pBlueBacHis C. A baculovirus vector that expresses the LBD
of PR as a nonfusion protein, was constructed by restriction
digestion of the plasmid pT7hbPR-A with RsrII and BclI to
drop out 1554 bp of PR cDNA spanning just 39 of the ATG
translation start site to the 59 boundary of the LBD (nucleotide
112 to 1566). The RsrII and BclI sites were ligated, linking the
LBD (aa 688–933) in frame with the ATG start site at aa
165–168. The entire LBD linked to the ATG start site of PR-A
was excised with NcoI and EcoRI and cloned into the BglII
and EcoRI sites of the baculovirus transfer plasmid, pVL1392
(Invitrogen). A baculovirus vector expressing the PR LBD as
a polyhistidine-tagged fusion protein (LBDhis) was con-
structed by restriction digestion of pT7hbPR-A with BclI and
EcoRI, to yield a PR cDNA encoding aa residues 688 to 933.
This DNA fragment was gel purified and inserted between the
HindIII and BamHI sites of the multiple cloning cassette of
pBlueBacHis C.
A baculovirus vector expressing the ANhis (the amino ter-
minus of PR-A that lacks the DBD, hinge, and LBD, as an
N-terminal polyhistidine-tagged fusion protein) was con-
structed by restriction digestion of the PR-Ahis plasmid by
EcoNI to drop out bp 1779–2671 of PR-A cDNA. The EcoNI
ends were made blunt by digestion with Mung Bean nuclease
and then religated resulting in a cDNA encoding a PR frag-
ment aa 165–535. A baculovirus vector expressing the
ANDBDhis (the amino terminus of PR-A including the DBD
and hinge, but lacking the LBD, as an N-terminal polyhisti-
dine-tagged fusion protein) was constructed by restriction
digestion of the plasmid pT7hBPR-A by BclI. After filling in by
Klenow, the fragment was cut with NcoI and gel purified. The
1.5-kb fragment was inserted into pBlueBacHIS2B plasmid
between the NcoI site and HindIII site, which had been
blunted by Mung Bean nuclease, resulting in a cDNA encod-
ing a PR fragment aa 165–633.
Baculovirus Expression of PR Constructs
Sf9 insect cells were cotransfected with the appropriate re-
combinant transfer plasmids above and wild type AcNPV
baculovirus DNA as described previously (65). Recombinant
viruses, which formed by homologous recombination, were
then isolated by plaque-purification (65). For production of
PR or PR fragments, Spodoptera frugiperda (Sf9) insect cells
were grown in spinner vessels (150 to 500 ml) in Graces
insect cell medium supplemented with 10% FBS (Hyclone
Labs, Logan, UT) at a multiplicity of infection of 1.0 for 48 h
at 27 C.
For the cooperative-ligand binding assays, frozen cell pel-
lets containing expressed PR constructs were shipped on dry
ice to Wayne State University and then stored in a 280 C
freezer until use. Each cell pellet generated from 300-ml
spinner vessels contained approximately 30 3 106 cells and
100 pmol receptor. Except for insect cells used in coopera-
tive ligand-binding assays and experiments in which ligand
was absent, all other insect cell cultures were incubated with
200 nM R5020 for the final 6 h of infection before harvest.
Coimmunoprecipitation of PR and PR Fragments
To prepare whole-cell extracts, Sf9 cells were lysed in TEDG
buffer (10 mM Tris-base, pH 7.4, 1 mM EDTA, 1 mM dithio-
threitol (DTT), and 10% glycerol), containing 0.5 M NaCl and
a mixture of protease inhibitors (28). Cell lysates were cen-
trifuged at 100,000 3 g for 30 min to yield a soluble super-
natant and then dialyzed against the lysis buffer containing
no NaCl. Protein A Sepharose was precoated noncovalently
with receptor-specific MAbs and used as an immunoabsor-
bent as described previously (23). Resins were prebound to
rabbit antimouse IgG (Cappel, Durham, N.C.), used as a
bridging antibody. Receptor-specific MAbs were then bound
to the immobilized rabbit antimouse IgG. Sf9 cell extracts
containing PR or PR fragments were mixed together in sili-
conized microcentrifuge tubes and incubated on ice for 30
min. Equal amounts of receptors were added to each assay
as determined by hormone-binding assay and Western blot
analysis. MAb-coated protein A-Sepharose beads (100 ml)
were added to each tube and incubated at 4 C for 3 h on an
end-over-end rotator. Resins were washed four times by
centrifugation in TEG buffer (TEDG minus dithiothreitol) con-
taining 100 mM NaCl, transferred to a new microcentrifuge
tube, and washed twice more. Immobilized proteins were
eluted with 2% SDS loading buffer and then analyzed by
Western Blot, using [35S]protein A and autoradiography as
the detection method. Dried nitrocellulose blots were
scanned directly for 35S in protein bands with a series 400
PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
Cooperative Ligand-Binding Assays
Cell pellets were homogenized on ice using a Potter-Elve-
hjem tissue grinder in 40 mM Tris/5 mM DTT/0.1 mM EDTA/
10% (vol/vol) glycerol, pH 7.4 (TEDG buffer) with 10 mM
sodium molybdate, 20 mg/ml ovalbumin, and 0.2 mM phe-
nylmethylsulfonyl fluoride. Final concentrations of 47 mg/ml
leupeptin and 1 mg/ml pepstatin were added, and the cell
homogenate was centrifuged at 100,000 3 g for 30 min at 2
C. The supernatant (cytosol) containing the expressed recep-
tor was used for equilibrium binding experiments.
Aliquots of the cytosol (200 ml) were incubated in duplicate
for 2 h in an ice water bath with concentrations of [3H]pro-
gesterone between 0.5 nM and 40 nM. The nonspecific bind-
ing was measured by a parallel incubation of the receptor
with [3H]progesterone in the presence of a 200-fold molar
excess of unlabeled progesterone. At the completion of the
incubation, 50 ml of each incubation mixture were removed
for determination of its total [3H]progesterone concentration.
Then 100 ml of 1% (wt/vol) charcoal/0.01% (wt/vol) dextran
T-500 in TDE buffer was added to each tube. The suspension
was incubated for 10 min at 0 C for adsorption of unbound
progesterone. The tubes were centrifuged at 4,000 3 g for 5
min, and 100 ml of the supernatant were removed for mea-
surement of bound [3H]progesterone by liquid scintillation
counting. An incubation period of 2 h at 0 C was shown to be
sufficient for equilibrium binding of [3H]progesterone to each
PR construct (results not shown).
To assess the stability of the receptor during each exper-
iment, the amount of specifically bound [3H]progesterone at
a saturating concentration of ligand was measured in cytosol
to which ligand was added immediately and in cytosol which
was kept at 0 C for 2 h before the addition of ligand. This
measured the degree of inactivation of the hormone-free
receptor during the incubation conditions. If the amount of
receptor-binding sites in the cytosol that had been kept at 0
C for 2 h before the addition of ligand was less than 90% of
the amount of receptor in the cytosol to which ligand had
been added immediately, data from that experiment were
discarded.
Enzymatic Cleavage of the Polyhistidine Tag
Extracts of Sf9 cells expressing hLBDhis, DhLBDhis, or PR-
Ahis were bound to metal ion affinity resins (Talon, ClonTech)
in TG buffer, pH 8.0, containing 350 mM NaCl and 5 mM
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imidazole in a siliconized 15-ml tube. The resin was washed
twice in the same buffer and twice in the same buffer con-
taining no NaCl and then transferred to a siliconized micro-
centrifuge tube. EnterokinaseMax (Invitrogen) was added (2
U/mg protein) to the immobilized polyhistidine-tagged protein
and incubated at 4 C for 16 h on an end-over-end rotator. The
final suspension was brought to 0.5 M NaCl and incubated for
another 30 min at 4 C. The supernatant with the cleaved
receptor was collected by centrifugation at 1,500 rpm. The
resin was washed four times with 0.5 ml of TG buffer con-
taining 0.5 M NaCl to collect any residual cleaved protein.
EnterokinaseMax enzyme was removed by incubating the
cleaved receptor with soybean trypsin inhibitor affinity resins
(Sigma) at 4 C for 2 h on an end-over-end rotator. The
enterokinase-free cleaved receptor was dialyzed against TG
buffer and analyzed by Western blot and silver-stained SDS-
gel electrophoresis.
IMAC Pull-Down Assays to Detect PR-PR Interactions
Whole-cell extracts were prepared as described above for
the coimmunoprecipitation assays except that the lysis buffer
contained no EDTA or DTT, which inhibits binding to the
metal ion resin. Whole-cell extracts containing PR polypep-
tides were mixed with polyhistidine-tagged versions of the
same polypeptides in siliconized microcentrifuge tubes for 30
min on ice. Each reaction was then brought to a total volume
of 100 ml with buffer containing 20 mM Tris, pH 8.0, and 10%
glycerol (TG) and then TG buffer containing 45 mM imidazole
and 300 mM NaCl was added to bring the final imidazole
concentration to 15 mM and NaCl to 100 mM. One hundred
microliters of a 1:1 suspension of Talon metal affinity resin
(Clontech), was added to each tube. Samples were incubated
at 4 C for 1 h on an end-over-end rotator followed by washing
of the resins four times by centrifugation in TG buffer
containing 15 mM imidazole and 100 mM NaCl. Resins were
transferred to a new microcentrifuge tube and washed
twice more. Bound proteins were extracted with 2% SDS
sample buffer and analyzed by Western blot with the PR
carboxyl-terminal MAb, C-262, using [35S]protein A and
autoradiography as the detection method. Dried nitrocel-
lulose blots were scanned directly for 35S in receptor
bands with a PhosphorImager.
In control experiments, PR-containing Sf9 cell extracts
were treated with micrococcal nuclease (Boehringer Mann-
heim, Indianapolis, IN) to destroy any contaminating DNA that
might affect PR-PR interactions. Approximately 1.5 U of en-
zyme was added per IMAC assay in the presence of 4 mM
CaCl2 during the preincubation of 30 min at 0–4 C. This was
followed by addition of another 1.5 U of enzyme during the
incubation with Talon resins. In parallel reactions to deter-
mine the activity of the micrococcal nuclease at 0–4 C, Sf9
cell extracts were spiked with 1 mg of a plasmid DNA. Com-
plete digestion of the test DNA was observed.
SDS-PAGE and Western Blotting
PR and PR fragments were electrophoresed on 10 or 7.5%
polyacrylamide SDS gels as previously described (23, 28, 67).
Separated proteins were transferred to nitrocellulose paper
and detected by Western blot assays with receptor-specific
MAbs (B-30, AB-52, N-559, or C-262) using either immuno-
peroxidase staining or [35S]protein A (Amersham, Arlington
Heights, IL) and autoradiography as described previously (22,
28, 67).
Steroid-Binding Assay for PR Quantification and
Specificity
To determine the picomoles per ml of PR polypeptides in
whole cell extracts of Sf9 cells, samples were incubated with
a single saturating dose of [3H]R5020 (20 nM) in the presence
or absence of 4 uM unlabeled R5020. Free and bound ste-
roids were separated by dextran-coated charcoal (DCC), and
the amount of [3H]R5020 binding was quantified by liquid
scintillation counting as described previously (28). Competi-
tive binding assays were done by incubating receptor cy-
tosols with increasing amounts of unlabeled steroids in the
presence of a saturating dose of 10 nM [3H]R5020 for 4 h in
ice-water bath (0–4 C). Bound and free [3H] R5020 were
separated by DCC.
Coimmunoprecipitation of in Vitro Synthesized LBD
with a Monoclonal Antibody to hsp90
The LBD of PR was synthesized in vitro by a coupled tran-
scription/translation assay using the Promega TNT kit. The
plasmid for in vitro synthesis was pT7bhLBD for the LBD of
PR (aa 688–933). The LBD was transcribed by T7 RNA poly-
merase and RNA was translated in nuclease treated rabbit
reticulocyte lysates in the presence of [35S]methionine (32).
To detect hsp90 complexes, translated LBD was coimmuno-
precipitated with the 3G3 MAb to hsp90 as described by
Perdew et al. (36) and radiolabeled LBD was detected by SDS
gel electrophoresis and autoradiography.
Data Analysis
For the results from coimmunoprecipitation and IMAC pull-
down assays, comparison was done by ANOVA using Excel
5.0 (Microsoft, Redmond, WA) to determine whether there
was a significant difference among groups. Bound and free
concentrations of [3H]progesterone were calculated using
Quattro Pro (Borland International Inc., Scotts Valley, CA).
The receptor concentration (Bmax) and Hill coefficient were
calculated by nonlinear regression using Enzfitter (Elsevier-
Biosoft, Cambridge, UK). The association constant (Ka) was
calculated from the limiting slope of the Scatchard plot (68).
The results for the different PR constructs were compared by
ANOVA followed by Bonferroni’s test for all pairwise compar-
isons using SigmaStat (v 1.0, Jandel Scientific, San Rafael,
CA). Positive results were statistically significant at a proba-
bility of less than 0.05.
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